Fenebrutinib -impurities | Pharmaffiliates

Fenebrutinib

Fenebrutinib an orally administered, small molecule, agammaglobulinaemia tyrosine kinase inhibitor, is being developed by Genentech for the treatment of autoimmune disorders. Reference standards of Fenebrutinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Fenebrutinib - API Standards 
    [catalogue_number] => PA 06 1510000
    [category_ids] => ,81,123,78,75,76,82,
    [chemical_name] => 
    [weight] => 664.81
    [form] => C37H44N8O4
    [cas] => 1434048-34-6
    [pslug] => 1434048-34-6-fenebrutinib-pa061510000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 06 1510000

Fenebrutinib - API Standards


  • Catalogue No.:PA 06 1510000

  • CAS :

    1434048-34-6

  • Molecular Formula : C37H44N8O4

  • Molecular Weight : 664.81